Wun-Huei Lin

Title: Wun-Huei Lin: Innovator in Antibody-Drug Conjugates

Introduction

Wun-Huei Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Wun-Huei Lin's latest patents include groundbreaking research on antibody-drug conjugates. One of his notable patents is titled "Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof." This patent describes an immunoconjugate that includes an antibody specifically binding to mesothelin, along with a linker and two payloads for cancer treatment. Another significant patent is "Antibody-drug conjugates and uses thereof," which involves an immunoconjugate comprising an anti-EGFR antibody and a kinase inhibitor. These patents highlight his commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Wun-Huei Lin has worked with esteemed organizations such as the Development Center for Biotechnology and Tunghai University. His experience in these institutions has allowed him to collaborate on various innovative projects that push the boundaries of medical science.

Collaborations

Wun-Huei Lin has collaborated with notable colleagues, including Shih-Hsien Chuang and Wei-Ting Sun. These partnerships have contributed to the success of his research and the development of new therapeutic approaches.

Conclusion

Wun-Huei Lin's contributions to the field of biotechnology, particularly in antibody-drug conjugates, demonstrate his innovative spirit and dedication to improving cancer treatment. His patents and collaborations reflect a commitment to advancing medical science and enhancing patient care.